Durán, Ignacio
Instituto de Biomedicina de Sevilla · Hospital Universitario Virgen del Rocío · Universidad de Sevilla
2 papers on CoChatORCID 0000-0001-8571-7163
Most cited papers
- Verified
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Balar, A. V., Galsky, M. D., Rosenberg, J. E., Powles, T., Petrylak, D. P., Bellmunt, J., Loriot, Y., Necchi, A., Hoffman-Censits, J., Perez-Gracia, J. L., et al. (2017) · The Lancet
Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers
Cited by 2,199
- Verified
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Powles, T., Durán, I., van der Heijden, M. S., Loriot, Y., Vogelzang, N. J., De Giorgi, U., Oudard, S., Retz, M. M., Castellano, D., Bamias, A., et al. (2018) · The Lancet
Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers
Cited by 1,408
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free